Le Lézard
Classified in: Health, Science and technology
Subject: Event

Halloran Consulting Group Launches Speaker Series to Drive Meaningful Discussions and Share Insights on Medical Advancements in the Life Science Industry


Halloran Consulting Group, a life science regulatory, quality and clinical consulting firm, today announced the launch of its Speaker Series, an interactive speaking circuit featuring Halloran's most experienced strategic thinkers. Halloran's consultants will share insights and progressive strategies for solving some of the biggest challenges facing the life science industry with the plan of offering several Speaker Series events throughout Massachusetts and California in 2020.

"As trusted partners and subject matter experts, Halloran is brought in to advise life science companies on clinical, quality, regulatory and organizational needs. We are fortunate to bring our expertise to so many development programs and companies and are proud to have been instrumental in the advancement of transformative therapeutic products," said Katie McCarthy, Chief Development Officer of Halloran Consulting Group. "With so much expertise and experience in-house, we felt it was our responsibility to provide a platform for our thought leaders to share their insights to help advance the development of tomorrow's products."

Halloran works with one of the most expansive and relevant clinical pipelines in the industry on behalf of startups, small-to-mid-sized biotechs and established pharmaceutical companies. Collectively, the team has earned a reputation amongst its peers for their breadth and depth in worldwide regulatory affairs, quality assurance, clinical development and organizational management.

"Halloran Consulting was founded on the belief that every company should have access to the insights that can only come from the experience of bringing new therapies efficiently into and successfully through development," said Laurie Halloran, Chief Executive Officer and Chairwoman of the Board of Halloran Consulting Group. "We have been fortunate to have those direct insights from years of ongoing work with our clients, and we want to bring them to a public forum so today's groundbreaking science has optimal potential to get out of the lab and to the patients who need them. This program was created to provide a platform to share our insights with the life science community."

The first installment of the Halloran Speaker Series is set to take place on Tuesday, November 12, 2019 from 5:00 p.m. ? 7:00 p.m. PST at BioLabs San Diego ? Towne Centre (9620 Towne Centre Drive, Suite 100, San Diego, CA 92121). Sheila Gwizdak, Vice President of Quality, will be speaking about the importance of "Quality as a Culture," as it creates an environment focused on transparency and continuous improvement through effective and repeatable processes and outcomes. To register and receive updates on future installments to the Halloran Speaker Series, please visit our event page.

Our second installment of the Halloran Speaker Series is scheduled to take place on Wednesday, December 4, 2019 at BioLabs San Diego ? Towne Centre (9620 Towne Centre Drive, Suite 100, San Diego, CA 92121). Kathrin Schalper, Ph.D., will be leading a discussion on "Strategies for Streamlining Development Programs" that will touch on taking advantage of special designations and small business status, leveraging different geographies for clinical studies, expediting CMC development, strategically engaging agencies at the right time on the right subject and accelerating approval using conditional marketing authorizations.

About BioLabs and BioLabs San Diego

A membership-based network of shared laboratory facilities located in key geographies with proven biotech innovation clusters, BioLabs offers beautifully designed coworking environments that pair fully equipped and supported lab, office, and event spaces with relevant programming and unparalleled access to capital and industry partners. These fertile, supportive ecosystems allow young companies to shift their focus from startup operations to experimentation and innovation so they can reach their scientific potential quickly and achieve business success. Companies can start with a single lab bench and scale up as they grow. The expanding BioLabs network now comprises sites in Boston and Cambridge, Massachusetts; Durham, North Carolina; San Carlos, San Diego, Los Angeles and San Francisco, California; New York City, and Princeton, New Jersey; and Philadelphia, Pennsylvania; and is developing sites with international partners as well.

About Halloran Consulting Group

Halloran is a life science regulatory, quality and clinical consulting firm that provides deep and broad domain expertise tailored to each client relationship. Our team is a trusted partner with subject matter experts, proven by our track record across a long-standing and diverse client base. Halloran's highly experienced team delivers a flexible and integrated partnership approach that successfully propels clients to their next inflection point. In working with one of the most expansive and relevant clinical pipelines in the industry, Halloran empowers its clients to optimize their organizations and achieve their next development milestone. For more information, please visit: www.hallorancg.com.


These press releases may also interest you

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...

at 17:00
The Doctors Company, the nation's largest physician-owned medical malpractice insurer, announced today that it has approved a 2024 premium dividend of approximately $14.7 million, bringing the total of declared dividends to date to $470 million....

at 17:00
Northern Virginia Oral, Maxillofacial & Implant Surgery ("NOVA OMS") has learned of a data security incident that may have impacted data belonging to certain patients and guarantors. On October 5, 2023, NOVA OMS became aware of unusual activity on...

at 17:00
The Journey Venture Studio announced today a strategic collaboration with Valleywise Health, a comprehensive healthcare system with locations throughout the Phoenix metro area. In pursuit of fostering innovation, this collaboration is set to...



News published on and distributed by: